Home blood pressure –guided antihypertensive therapy in chronic kidney disease: more data are needed

In the era of newly introduced hypertension guidelines recommending lower blood pressure (BP) targets for drug-treated hypertensives, the necessity for optimized management of hypertension becomes even more urgent. The concept of home BP –guided antihypertensive therapy is for long suggested as a simple and feasible approach to improve BP control rates and optimize the management of hypertension. Home BP–guided antihypertensive therapy is particularly applicable to hypertensives with chronic kidney disease (CKD) for several reas ons including the following: (1) difficult-to-control BP and high BP variability in the CKD setting; (2) poor accuracy of office BP in determining hypertension control status and detecting “white-coat” and “masked” hypertension; (3) poor value of routine office BP recordings in predicting th e longitudinal progression of target-organ damage; and (4) superiority of home BP over office BP recordings in prognosticating the risk of incident end-stage renal disease or death.

Source: Journal of the American Society of Hypertension - February 10, 2018 Category: Cardiology Authors: Panagiotis I. Georgianos, Eleni Champidou, Vassilios Liakopoulos, Elias V. Balaskas, Pantelis E. Zebekakis Tags: Commentary Source Type: research